Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Marilyn Manco-Johnson to Infant

This is a "connection" page, showing publications Marilyn Manco-Johnson has written about Infant.

 
Connection Strength
  
 
 
1.470
  
  1. Warren BB, Thornhill D, Singer-Fox L, Smith J, Funk S, Manco-Johnson M. Haemophilia Joint Health Score Ranges Across the Lifespan: Variation by Haemophilia Type and Severity. Haemophilia. 2026 Jul-Aug; 32(4):1016-1024.
    View in: PubMed
    Score: 0.087
  2. Manco-Johnson M, Brons P, Knoebl P, Wang M, Siffel C, Turecek PL, Gazda HT. Real-world use of protein C concentrate for the treatment of patients with protein C deficiency: an international registry. J Thromb Haemost. 2025 11; 23(11):3569-3577.
    View in: PubMed
    Score: 0.083
  3. Manco-Johnson MJ, Annam A, Schardt T. Anticoagulation in Pediatric Patients. Tech Vasc Interv Radiol. 2024 Jun; 27(2):100958.
    View in: PubMed
    Score: 0.077
  4. Warren BB, Moyer GC, Manco-Johnson MJ. Hemostasis in the Pregnant Woman, the Placenta, the Fetus, and the Newborn Infant. Semin Thromb Hemost. 2023 Jun; 49(4):319-329.
    View in: PubMed
    Score: 0.070
  5. Smith J, Thornhill D, Goldenberg NA, Brandão L, Knapp-Clevenger R, Warren BB, Sung L, Kahn SR, Manco-Johnson M. Validation of Outcome Instruments for Pediatric Postthrombotic Syndrome: Introducing the Peds-VEINES-QOL, a New Health-Related Quality of Life Instrument. Thromb Haemost. 2021 Oct; 121(10):1367-1375.
    View in: PubMed
    Score: 0.061
  6. Warren BB, Thornhill D, Stein J, Fadell M, Ingram JD, Funk S, Norton KL, Lane HD, Bennett CM, Dunn A, Recht M, Shapiro A, Manco-Johnson MJ. Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study. Blood Adv. 2020 06 09; 4(11):2451-2459.
    View in: PubMed
    Score: 0.058
  7. Manco-Johnson MJ, Byams VR, Recht M, Dudley B, Dupervil B, Aschman DJ, Oakley M, Kapica S, Voutsis M, Humes S, Kulkarni R, Grant AM. Community counts: Evolution of a national surveillance system for bleeding disorders. Am J Hematol. 2018 06; 93(6):E137-E140.
    View in: PubMed
    Score: 0.050
  8. Branchford BR, Ruegg K, Villalobos-Menuey E, Jacobson LJ, Di Paola JA, Manco-Johnson M. FVIII/VWF ratio is not a reliable predictor of VWD in children. Pediatr Blood Cancer. 2014 May; 61(5):936-9.
    View in: PubMed
    Score: 0.037
  9. Joachim E, Goldenberg NA, Bernard TJ, Armstrong-Wells J, Stabler S, Manco-Johnson MJ. The methylenetetrahydrofolate reductase polymorphism (MTHFR c.677C>T) and elevated plasma homocysteine levels in a U.S. pediatric population with incident thromboembolism. Thromb Res. 2013 Aug; 132(2):170-4.
    View in: PubMed
    Score: 0.036
  10. Goldenberg NA, Bernard TJ, Hillhouse J, Armstrong-Wells J, Galinkin J, Knapp-Clevenger R, Jacobson L, Marcovina SM, Manco-Johnson MJ. Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children. Haematologica. 2013 May; 98(5):802-7.
    View in: PubMed
    Score: 0.035
  11. Bornikova L, Peyvandi F, Allen G, Bernstein J, Manco-Johnson MJ. Fibrinogen replacement therapy for congenital fibrinogen deficiency. J Thromb Haemost. 2011 Sep; 9(9):1687-704.
    View in: PubMed
    Score: 0.032
  12. Gill JC, Shapiro A, Valentino LA, Bernstein J, Friedman C, Nichols WL, Manco-Johnson M. von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease. Haemophilia. 2011 Nov; 17(6):895-905.
    View in: PubMed
    Score: 0.031
  13. Goldenberg NA, Pounder E, Knapp-Clevenger R, Manco-Johnson MJ. Validation of upper extremity post-thrombotic syndrome outcome measurement in children. J Pediatr. 2010 Nov; 157(5):852-5.
    View in: PubMed
    Score: 0.030
  14. Goldenberg NA, Manco-Johnson MJ. Protein C deficiency. Haemophilia. 2008 Nov; 14(6):1214-21.
    View in: PubMed
    Score: 0.026
  15. Goldenberg NA, Bombardier C, Hathaway WE, McFarland K, Jacobson L, Manco-Johnson MJ. Influence of factor IX on overall plasma coagulability and fibrinolytic potential as measured by global assay: monitoring in haemophilia B. Haemophilia. 2008 Jan; 14(1):68-77.
    View in: PubMed
    Score: 0.024
  16. Manco-Johnson M. Comparing prophylaxis with episodic treatment in haemophilia A: implications for clinical practice. Haemophilia. 2007 Sep; 13 Suppl 2:4-9.
    View in: PubMed
    Score: 0.024
  17. Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R, Ingram JD, Manco-Johnson ML, Funk S, Jacobson L, Valentino LA, Hoots WK, Buchanan GR, DiMichele D, Recht M, Brown D, Leissinger C, Bleak S, Cohen A, Mathew P, Matsunaga A, Medeiros D, Nugent D, Thomas GA, Thompson AA, McRedmond K, Soucie JM, Austin H, Evatt BL. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007 Aug 09; 357(6):535-44.
    View in: PubMed
    Score: 0.024
  18. Hacker MR, Page JH, Shapiro AD, Rich-Edwards JW, Manco-Johnson MJ. Central venous access device infections in children with hemophilia: a comparison of prophylaxis and episodic therapy. J Pediatr Hematol Oncol. 2007 Jul; 29(7):458-64.
    View in: PubMed
    Score: 0.024
  19. Goldenberg NA, Durham JD, Knapp-Clevenger R, Manco-Johnson MJ. A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children. Blood. 2007 Jul 01; 110(1):45-53.
    View in: PubMed
    Score: 0.023
  20. Goldenberg NA, Hathaway WE, Jacobson L, McFarland K, Manco-Johnson MJ. Influence of factor VIII on overall coagulability and fibrinolytic potential of haemophilic plasma as measured by global assay: monitoring in haemophilia A. Haemophilia. 2006 Nov; 12(6):605-14.
    View in: PubMed
    Score: 0.023
  21. Hacker MR, Primeaux J, Manco-Johnson MJ. A patient satisfaction survey for haemophilia treatment centres. Haemophilia. 2006 Mar; 12(2):163-8.
    View in: PubMed
    Score: 0.022
  22. Goldenberg NA, Manco-Johnson MJ. Pediatric hemostasis and use of plasma components. Best Pract Res Clin Haematol. 2006; 19(1):143-55.
    View in: PubMed
    Score: 0.021
  23. Manco-Johnson MJ. How I treat venous thrombosis in children. Blood. 2006 Jan 01; 107(1):21-9.
    View in: PubMed
    Score: 0.021
  24. Manco-Johnson MJ. Etiopathogenesis of pediatric thrombosis. Hematology. 2005; 10 Suppl 1:167-70.
    View in: PubMed
    Score: 0.020
  25. Journeycake JM, Manco-Johnson MJ. Thrombosis during infancy and childhood: what we know and what we do not know. Hematol Oncol Clin North Am. 2004 Dec; 18(6):1315-38, viii-ix.
    View in: PubMed
    Score: 0.020
  26. Goldenberg NA, Schulman S, Kittelson JM, Abshire TC, Casella JF, Dale R, Halperin JL, Hanson J, Kessler CM, Manco-Johnson MJ, McDevitt L, Sidonio RF, Spyropoulos AC, Steg PG, Bonaca MP. Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years. J Thromb Haemost. 2025 02; 23(2):651-656.
    View in: PubMed
    Score: 0.020
  27. Herzog E, Zavaletta V, Katz D, Lindquist J, Manco-Johnson M, Schardt T, Annam A. Interventional Treatment of Pediatric Venous Thromboembolic Disease. Tech Vasc Interv Radiol. 2024 Jun; 27(2):100957.
    View in: PubMed
    Score: 0.019
  28. Han JH, Dupervil B, Mahajerin A, Kulkarni R, Manco-Johnson M, Thornburg C. Clinical and treatment characteristics of infants and toddlers less than 2 years of age with hemophilia. Blood Adv. 2024 06 11; 8(11):2707-2717.
    View in: PubMed
    Score: 0.019
  29. Manco-Johnson M, Morrissey-Harding G, Edelman-Lewis B, Oster G, Larson P. Development and validation of a measure of disease-specific quality of life in young children with haemophilia. Haemophilia. 2004 Jan; 10(1):34-41.
    View in: PubMed
    Score: 0.019
  30. Manco-Johnson MJ. Update on treatment regimens: prophylaxis versus on-demand therapy. Semin Hematol. 2003 Jul; 40(3 Suppl 3):3-9.
    View in: PubMed
    Score: 0.018
  31. Blanchette VS, McCready M, Achonu C, Abdolell M, Rivard G, Manco-Johnson MJ. A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres. Haemophilia. 2003 May; 9 Suppl 1:19-26; discussion 26.
    View in: PubMed
    Score: 0.018
  32. Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA, Halperin JL, Hamblin F, Kessler CM, Manco-Johnson MJ, Sidonio RF, Spyropoulos AC, Steg PG, Turpie AGG, Schulman S. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial. JAMA. 2022 01 11; 327(2):129-137.
    View in: PubMed
    Score: 0.016
  33. Josephson C, Nuss R, Jacobson L, Hacker MR, Murphy J, Weinberg A, Manco-Johnson MJ. The varicella-autoantibody syndrome. Pediatr Res. 2001 Sep; 50(3):345-52.
    View in: PubMed
    Score: 0.016
  34. Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia. 2001 Jul; 7(4):392-6.
    View in: PubMed
    Score: 0.016
  35. Manco-Johnson MJ, Nuss R. Thrombophilia in the infant and child. Adv Pediatr. 2001; 48:363-84.
    View in: PubMed
    Score: 0.015
  36. Maher KN, Gibson E, Warren BB, Funk SM, Shearer R, Buckner TW, Wang M, Manco-Johnson MJ, Ng CJ. Prophylaxis for children with moderate hemophilia: Use of a guideline to increase early initiation. Pediatr Blood Cancer. 2021 01; 68(1):e28577.
    View in: PubMed
    Score: 0.015
  37. Manco-Johnson MJ, Nuss R, Jacobson LJ. Heparin neutralization is essential for accurate measurement of factor VIII activity and inhibitor assays in blood samples drawn from implanted venous access devices. J Lab Clin Med. 2000 Jul; 136(1):74-9.
    View in: PubMed
    Score: 0.015
  38. Manco-Johnson MJ, Nuss R, Hays T, Krupski W, Drose J, Manco-Johnson ML. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr. 2000 Apr; 136(4):446-53.
    View in: PubMed
    Score: 0.014
  39. Kim JS, Kaufman J, Patel SS, Manco-Johnson M, Di Paola J, da Cruz EM. Antiplatelet Effect of Ketorolac in Children After Congenital Cardiac Surgery. World J Pediatr Congenit Heart Surg. 2018 11; 9(6):651-658.
    View in: PubMed
    Score: 0.013
  40. Andersson NG, Auerswald G, Barnes C, Carcao M, Dunn AL, Fijnvandraat K, Hoffmann M, Kavakli K, Kenet G, Kobelt R, Kurnik K, Liesner R, Mäkipernaa A, Manco-Johnson MJ, Mancuso ME, Molinari AC, Nolan B, Perez Garrido R, Petrini P, Platokouki HE, Shapiro AD, Wu R, Ljung R. Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment. Br J Haematol. 2017 10; 179(2):298-307.
    View in: PubMed
    Score: 0.012
  41. Manco-Johnson MJ. Disorders of hemostasis in childhood: risk factors for venous thromboembolism. Thromb Haemost. 1997 Jul; 78(1):710-4.
    View in: PubMed
    Score: 0.012
  42. Sifontes MT, Nuss R, Hunger SP, Wilimas J, Jacobson LJ, Manco-Johnson MJ. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol. 1997 Mar; 96(3):484-9.
    View in: PubMed
    Score: 0.012
  43. Kulkarni R, Presley RJ, Lusher JM, Shapiro AD, Gill JC, Manco-Johnson M, Koerper MA, Abshire TC, DiMichele D, Hoots WK, Mathew P, Nugent DJ, Geraghty S, Evatt BL, Soucie JM. Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System. Haemophilia. 2017 Mar; 23(2):207-214.
    View in: PubMed
    Score: 0.011
  44. Boylan B, Rice AS, Neff AT, Manco-Johnson MJ, Kempton CL, Miller CH. Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay. J Thromb Haemost. 2016 10; 14(10):1931-1940.
    View in: PubMed
    Score: 0.011
  45. Peyvandi F, Mannucci PM, Garagiola I, El-Beshlawy A, Elalfy M, Ramanan V, Eshghi P, Hanagavadi S, Varadarajan R, Karimi M, Manglani MV, Ross C, Young G, Seth T, Apte S, Nayak DM, Santagostino E, Mancuso ME, Sandoval Gonzalez AC, Mahlangu JN, Bonanad Boix S, Cerqueira M, Ewing NP, Male C, Owaidah T, Soto Arellano V, Kobrinsky NL, Majumdar S, Perez Garrido R, Sachdeva A, Simpson M, Thomas M, Zanon E, Antmen B, Kavakli K, Manco-Johnson MJ, Martinez M, Marzouka E, Mazzucconi MG, Neme D, Palomo Bravo A, Paredes Aguilera R, Prezotti A, Schmitt K, Wicklund BM, Zulfikar B, Rosendaal FR. A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A. N Engl J Med. 2016 May 26; 374(21):2054-64.
    View in: PubMed
    Score: 0.011
  46. Manco-Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, Weinberg A, Lefkowitz J. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr. 1996 Mar; 128(3):319-23.
    View in: PubMed
    Score: 0.011
  47. Antun A, Monahan PE, Manco-Johnson MJ, Callaghan MU, Kanin M, Knoll C, Carpenter SL, Davis JA, Guerrera MF, Kruse-Jarres R, Ragni MV, Witmer C, McCracken CE, Kempton CL. Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study. J Thromb Haemost. 2015 Nov; 13(11):1980-8.
    View in: PubMed
    Score: 0.011
  48. Goldenberg NA, Abshire T, Blatchford PJ, Fenton LZ, Halperin JL, Hiatt WR, Kessler CM, Kittelson JM, Manco-Johnson MJ, Spyropoulos AC, Steg PG, Stence NV, Turpie AG, Schulman S. Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings. J Thromb Haemost. 2015 Sep; 13(9):1597-605.
    View in: PubMed
    Score: 0.010
  49. Nuss R, Hays T, Manco-Johnson M. Childhood thrombosis. Pediatrics. 1995 Aug; 96(2 Pt 1):291-4.
    View in: PubMed
    Score: 0.010
  50. Nakar C, Manco-Johnson MJ, Lail A, Donfield S, Maahs J, Chong Y, Blades T, Shapiro A. Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres. Haemophilia. 2015 May; 21(3):365-373.
    View in: PubMed
    Score: 0.010
  51. Nuss R, Hays T, Manco-Johnson M. Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Pediatr Hematol Oncol. 1994 May; 16(2):127-31.
    View in: PubMed
    Score: 0.010
  52. Soucie JM, Miller CH, Kelly FM, Payne AB, Creary M, Bockenstedt PL, Kempton CL, Manco-Johnson MJ, Neff AT. A study of prospective surveillance for inhibitors among persons with haemophilia in the United States. Haemophilia. 2014 Mar; 20(2):230-7.
    View in: PubMed
    Score: 0.009
  53. Landi D, Beckman MG, Shah NR, Bockenstedt P, Grant AM, Heit JA, Key NS, Kulkarni R, Manco-Johnson M, Moll S, Philipp CS, Andersen JC, Ortel TL. Characteristics of abdominal vein thrombosis in children and adults. Thromb Haemost. 2013 Apr; 109(4):625-32.
    View in: PubMed
    Score: 0.009
  54. Goldenberg NA, Jenkins S, Jack J, Armstrong-Wells J, Fenton LZ, Stence NV, Oleszek J, Boada R, Wilkening GN, Wilkinson C, Soep JB, Miyamoto SD, Bajaj L, Mourani PM, Manco-Johnson MJ, Bernard TJ. Arteriopathy, D-dimer, and risk of poor neurologic outcome in childhood-onset arterial ischemic stroke. J Pediatr. 2013 May; 162(5):1041-6.e1.
    View in: PubMed
    Score: 0.009
  55. Hancock HS, Wang M, Gist KM, Gibson E, Miyamoto SD, Mourani PM, Manco-Johnson MJ, Goldenberg NA. Cardiac findings and long-term thromboembolic outcomes following pulmonary embolism in children: a combined retrospective-prospective inception cohort study. Cardiol Young. 2013 Jun; 23(3):344-52.
    View in: PubMed
    Score: 0.009
  56. Bombardier C, Villalobos-Menuey E, Ruegg K, Hathaway WE, Manco-Johnson MJ, Goldenberg NA. Monitoring hypercoagulability and hypofibrinolysis following acute venous Thromboembolism in children: application of the CloFAL assay in a prospective inception cohort study. Thromb Res. 2012 Sep; 130(3):343-9.
    View in: PubMed
    Score: 0.008
  57. Kenet G, Aronis S, Berkun Y, Bonduel M, Chan A, Goldenberg NA, Holzhauer S, Iorio A, Journeycake J, Junker R, Male C, Manco-Johnson M, Massicotte P, Mesters R, Monagle P, van Ommen H, Rafini L, Simioni P, Young G, Nowak-Göttl U. Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis. Semin Thromb Hemost. 2011 Oct; 37(7):802-9.
    View in: PubMed
    Score: 0.008
  58. Branchford BR, Mourani P, Bajaj L, Manco-Johnson M, Wang M, Goldenberg NA. Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation. Haematologica. 2012 Apr; 97(4):509-15.
    View in: PubMed
    Score: 0.008
  59. Di Paola J, Lethagen S, Gill J, Mannucci P, Manco-Johnson M, Bernstein J, Nichols WL, Bergman GE. Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgery. Haemophilia. 2011 Sep; 17(5):752-8.
    View in: PubMed
    Score: 0.008
  60. Bernard TJ, Manco-Johnson MJ, Goldenberg NA. The roles of anatomic factors, thrombophilia, and antithrombotic therapies in childhood-onset arterial ischemic stroke. Thromb Res. 2011 Jan; 127(1):6-12.
    View in: PubMed
    Score: 0.007
  61. Calhoon MJ, Ross CN, Pounder E, Cassidy D, Manco-Johnson MJ, Goldenberg NA. High prevalence of thrombophilic traits in children with family history of thromboembolism. J Pediatr. 2010 Sep; 157(3):485-9.
    View in: PubMed
    Score: 0.007
  62. Goldenberg NA, Tripputi M, Crowther M, Abshire TC, DiMichele D, Manco-Johnson MJ, Hiatt WR. The "parallel-cohort RCT": Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism. Contemp Clin Trials. 2010 Jan; 31(1):131-3.
    View in: PubMed
    Score: 0.007
  63. Bernard TJ, Goldenberg NA, Tripputi M, Manco-Johnson MJ, Niederstadt T, Nowak-Göttl U. Anticoagulation in childhood-onset arterial ischemic stroke with non-moyamoya arteriopathy: findings from the Colorado and German (COAG) collaboration. Stroke. 2009 Aug; 40(8):2869-71.
    View in: PubMed
    Score: 0.007
  64. Young G, Becker S, Düring C, Friedrichs F, Goldenberg N, Kenet G, Manco-Johnson M, Scheffold C, Nowak-Göttl U. Influence of the factor II G20210A variant or the factor V G1691A mutation on symptomatic recurrent venous thromboembolism in children: an international multicenter cohort study. J Thromb Haemost. 2009 Jan; 7(1):72-9.
    View in: PubMed
    Score: 0.007
  65. Manco-Johnson MJ, Marlar RA, Jacobson LJ, Hays T, Warady BA. Severe protein C deficiency in newborn infants. J Pediatr. 1988 Aug; 113(2):359-63.
    View in: PubMed
    Score: 0.006
  66. Kreuz W, Gill JC, Rothschild C, Manco-Johnson MJ, Lusher JM, Kellermann E, Gorina E, Larson PJ. Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation. Thromb Haemost. 2005 Mar; 93(3):457-67.
    View in: PubMed
    Score: 0.005
  67. Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med. 2004 Sep 09; 351(11):1081-8.
    View in: PubMed
    Score: 0.005
  68. Wang M, Hays T, Balasa V, Bagatell R, Gruppo R, Grabowski EF, Valentino LA, Tsao-Wu G, Manco-Johnson MJ. Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol. 2003 May; 25(5):379-86.
    View in: PubMed
    Score: 0.004
  69. Young G, Manco-Johnson M, Gill JC, Dimichele DM, Tarantino MD, Abshire T, Nugent DJ. Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. J Thromb Haemost. 2003 May; 1(5):958-62.
    View in: PubMed
    Score: 0.004
  70. Brenner BR, Nowak-Göttl U, Kosch A, Manco-Johnson M, Laposata M. Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children. Arch Pathol Lab Med. 2002 Nov; 126(11):1296-303.
    View in: PubMed
    Score: 0.004
  71. Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC, Angiolillo AL, Luban NL, Sherman KE, Manco-Johnson M, Preiss L, Leissinger C, Kessler CM, Cohen AR, DiMichele D, Hilgartner MW, Aledort LM, Kroner BL, Rosenberg PS, Hatzakis A. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood. 2002 Sep 01; 100(5):1584-9.
    View in: PubMed
    Score: 0.004
  72. Soucie JM, Richardson LC, Evatt BL, Linden JV, Ewenstein BM, Stein SF, Leissinger C, Manco-Johnson M, Sexauer CL. Risk factors for infection with HBV and HCV in a largecohort of hemophiliac males. Transfusion. 2001 Mar; 41(3):338-43.
    View in: PubMed
    Score: 0.004
  73. David M, Manco-Johnson M, Andrew M. Diagnosis and treatment of venous thromboembolism in children and adolescents. On behalf of the Subcommittee on Perinatal Haemostasis of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1995 Aug; 74(2):791-2.
    View in: PubMed
    Score: 0.003
  74. Mahasandana C, Suvatte V, Marlar RA, Manco-Johnson MJ, Jacobson LJ, Hathaway WE. Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet. 1990 Jan 06; 335(8680):61-2.
    View in: PubMed
    Score: 0.002
  75. Sedman A, Bell P, Manco-Johnson M, Schrier R, Warady BA, Heard EO, Butler-Simon N, Gabow P. Autosomal dominant polycystic kidney disease in childhood: a longitudinal study. Kidney Int. 1987 Apr; 31(4):1000-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)